{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:00:59Z","timestamp":1777111259235,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.pcad.2012.04.003","type":"journal-article","created":{"date-parts":[[2012,6,9]],"date-time":"2012-06-09T02:16:17Z","timestamp":1339208177000},"page":"483-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["A Primer of Disopyramide Treatment of Obstructive Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"54","author":[{"given":"Mark V.","family":"Sherrid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milla","family":"Arabadjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2012.04.003_bb0005","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.287.10.1308","article-title":"Hypertrophic cardiomyopathy: a systematic review","volume":"287","author":"Maron","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2012.04.003_bb0010","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.04.003_bb0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.echo.2010.10.006","article-title":"Standing and exercise Doppler echocardiography in obstructive hypertrophic cardiomyopathy: the range of gradients with upright activity","volume":"24","author":"Joshi","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.pcad.2012.04.003_bb0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pcad.2006.08.001","article-title":"Pathophysiology and treatment of hypertrophic cardiomyopathy","volume":"49","author":"Sherrid","year":"2006","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2012.04.003_bb0025","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.04.003_bb0030","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/hrt.2007.126003","article-title":"Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy","volume":"94","author":"Shah","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2012.04.003_bb0035","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2012.04.003_bb0040","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/01.CIR.91.4.1189","article-title":"Papillary muscle displacement causes systolic anterior motion of the mitral valve. Experimental validation and insights into the mechanism of subaortic obstruction","volume":"91","author":"Levine","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.04.003_bb0045","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0002-8703(87)90701-0","article-title":"An integrated mechanism for systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy based on echocardiographic observations","volume":"113","author":"Jiang","year":"1987","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2012.04.003_bb0050","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0003-4975(02)04546-0","article-title":"Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction","volume":"75","author":"Sherrid","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.pcad.2012.04.003_bb0055","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/0735-1097(93)90196-8","article-title":"An echocardiographic study of the fluid mechanics of obstruction in hypertrophic cardiomyopathy","volume":"22","author":"Sherrid","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.04.003_bb0060","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0735-1097(00)00830-5","article-title":"Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy","volume":"36","author":"Sherrid","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.04.003_bb0065","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jacc.2009.03.052","article-title":"Reflections of inflections in hypertrophic cardiomyopathy","volume":"54","author":"Sherrid","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.04.003_bb0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0735-1097(87)80159-6","article-title":"Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy","volume":"10","author":"Cannon","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.04.003_bb0075","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/01.CIR.79.4.766","article-title":"Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy","volume":"79","author":"Cannon","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.04.003_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.CIR.97.1.41","article-title":"Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy","volume":"97","author":"Sherrid","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.04.003_bb0085","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.CIR.38.5.846","article-title":"Muscular subaortic stenosis. Prevention of outflow obstruction with propranolol","volume":"38","author":"Flamm","year":"1968","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.04.003_bb0090","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0002-9149(73)90012-X","article-title":"Hypertrophic subaortic stenosis. Clinical and hemodynamic effects of long-term propranolol therapy","volume":"31","author":"Stenson","year":"1973","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2012.04.003_bb0095","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijcard.2006.04.080","article-title":"Beta-blocker therapy for dynamic left ventricular outflow tract obstruction induced by exercise","volume":"117","author":"Cabrera-Bueno","year":"2007","journal-title":"Int J cardiol"},{"key":"10.1016\/j.pcad.2012.04.003_bb0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.CIR.64.3.437","article-title":"Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy","volume":"64","author":"Epstein","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.04.003_bb0105","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.amjcard.2010.06.059","article-title":"Comparison of acute reduction in left ventricular outflow tract pressure gradient in obstructive hypertrophic cardiomyopathy by disopyramide versus pilsicainide versus cibenzoline","volume":"106","author":"Kajimoto","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2012.04.003_bb0110","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2005.01.012","article-title":"Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy","volume":"45","author":"Sherrid","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.04.003_bb0115","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/01.CIR.92.7.1680","article-title":"Hypertrophic cardiomyopathy. Clinical spectrum and treatment","volume":"92","author":"Wigle","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.04.003_bb0120","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/hrt.2005.068577","article-title":"Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy","volume":"92","author":"Elliott","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2012.04.003_bb0125","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJM198210143071607","article-title":"Muscular subaortic stenosis: hemodynamic and clinical improvement after disopyramide","volume":"307","author":"Pollick","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2012.04.003_bb0130","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/0002-8703(93)90760-7","article-title":"Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy","volume":"125","author":"Kimball","year":"1993","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2012.04.003_bb0135","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0002-9149(88)90268-8","article-title":"Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration","volume":"62","author":"Pollick","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2012.04.003_bb0140","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/0002-9149(88)90553-X","article-title":"Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy","volume":"62","author":"Sherrid","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2012.04.003_bb0145","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/0002-9149(88)90269-X","article-title":"Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration","volume":"62","author":"Pollick","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2012.04.003_bb0150","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","article-title":"Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy","volume":"342","author":"Maron","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2012.04.003_bb0155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2012.04.003_bb0160","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0735-1097(87)80207-3","article-title":"Disopyramide-pyridostigmine interaction: selective reversal of anticholinergic symptoms with preservation of antiarrhythmic effect","volume":"10","author":"Teichman","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.04.003_bb0165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijcard.2008.11.088","article-title":"Synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy","volume":"141","author":"Minami","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2012.04.003_bb0170","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.84.3.1188","article-title":"Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction","volume":"84","author":"Klues","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.04.003_bb0175","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1161\/01.CIR.100.19.e99","article-title":"Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle","volume":"100","author":"Sigwart","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2012.04.003_bb0180","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.jacc.2011.02.033","article-title":"Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy","volume":"57","author":"Minami","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.04.003_bb0185","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0002-9149(94)90416-2","article-title":"Effects of disopyramide on left ventricular diastolic function in hypertrophic cardiomyopathy","volume":"74","author":"Fifer","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2012.04.003_bb0190","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0735-1097(95)00229-W","article-title":"Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy","volume":"26","author":"Matsubara","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2012.04.003_bb0195","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.athoracsur.2008.07.048","article-title":"Resection-plication-release for hypertrophic cardiomyopathy: clinical and echocardiographic follow-up","volume":"86","author":"Balaram","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.pcad.2012.04.003_bb0200","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.athoracsur.2007.07.063","article-title":"Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy","volume":"85","author":"Smedira","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.pcad.2012.04.003_bb0205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jtcvs.2011.10.059","article-title":"Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction","volume":"143","author":"Schaff","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pcad.2012.04.003_bb0210","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/CIRCULATIONAHA.107.694158","article-title":"Management of symptoms in hypertrophic cardiomyopathy","volume":"117","author":"Fifer","year":"2008","journal-title":"Circulation"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062012000461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062012000461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:14:18Z","timestamp":1758500058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062012000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0033062012000461"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2012.04.003","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Primer of Disopyramide Treatment of Obstructive Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2012.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}